Vectus Biosystems Ltd (VBS.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,685 | 43 | 42 | 517 |
| Marketable Securities | 31 | N/A | N/A | N/A |
| Income taxes - deferred | N/A | 32 | 25 | 78 |
| Other current assets | 79 | 0 | 0 | 0 |
| TOTAL | $2,919 | $159 | $150 | $654 |
| Non-Current Assets | ||||
| PPE Net | 79 | 35 | 46 | 66 |
| TOTAL | $79 | $35 | $46 | $66 |
| Total Assets | $2,998 | $194 | $196 | $721 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | N/A | 912 | N/A |
| Accounts payable and accrued liabilities | 606 | 1,120 | 981 | 74 |
| Other current liabilities | 455 | 523 | 281 | 254 |
| TOTAL | $1,447 | $1,962 | $2,440 | $593 |
| Non-Current Liabilities | ||||
| Long Term Debt | 7,160 | 1,958 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 13 | 11 |
| TOTAL | $7,196 | $1,962 | $13 | $11 |
| Total Liabilities | $8,643 | $3,924 | $2,453 | $604 |
| Shareholders' Equity | ||||
| Common Shares | 17,862 | 17,600 | 17,600 | 17,591 |
| Retained earnings | -24,843 | -21,847 | -20,251 | -17,663 |
| Other shareholders' equity | 1,336 | 517 | 394 | 188 |
| TOTAL | $-5,645 | $-3,730 | $-2,256 | $117 |
| Total Liabilities And Equity | $2,998 | $194 | $196 | $721 |